scholarly journals Efficacy of extracorporeal shockwave lithotripsy with furosemide and hydration in renal stone management: A randomised controlled trial

2019 ◽  
Vol 17 (4) ◽  
pp. 279-284
Author(s):  
Safiullah Sohu ◽  
Munawar Hussain Soomro ◽  
Riaz Hussain Mangrio ◽  
Arif Ali Shaikh ◽  
Azizullah Mirani ◽  
...  
Keyword(s):  
Randomised Controlled Trial ◽  
Renal Stone ◽  
Controlled Trial ◽  
Extracorporeal Shockwave Lithotripsy ◽  
Shockwave Lithotripsy ◽  
Extracorporeal Shockwave ◽  
Randomised Controlled

scholarly journals Comparison between prolozone therapy and extracorporeal shockwave therapy in management of pain and function in resistant cases of lateral epicondylitis: a randomised controlled trial

2020 ◽  
Vol 7 (8) ◽  
pp. 1216
Author(s):  
Margaret Chabungbam ◽  
Akoijam Joy Singh ◽  
Longjam Nilachandra Singh ◽  
Yumnam Ningthemba ◽  
Sreejith C. ◽  
...  
Keyword(s):  
Randomised Controlled Trial ◽  
Tennis Elbow ◽  
Controlled Trial ◽  
Lateral Epicondylitis ◽  
Painful Condition ◽  
Extracorporeal Shockwave Therapy ◽  
Extracorporeal Shockwave ◽  
Shockwave Therapy ◽  
Vas Score ◽  
Randomised Controlled

Background: Lateral epicondylitis also known as the tennis elbow is a painful condition of the elbow caused by overuse. The disease imparts significant disability to those affected in terms of the quantity and quality of work done.Methods: A randomised controlled trial was conducted in the Department of Physical Medicine and Rehabilitation, RIMS, Imphal for a period of 1 year from February 2017 to January 2018. Eighty-four patients with resistant lateral epicondylitis recruited were divided into 2 groups- group A received Prolozone injection while group B underwent Extracorporeal Shockwave Therapy (ESWT).Results: Assessments of VAS (Visual Analog Scale) and PRTEE (Patient Rated Tennis Elbow Evaluation) were done at 8 weeks and 24 weeks. The mean VAS score in Prolozone group improved from 7.22±0.89 to 4.04±1.01 at 8 weeks to 1.67±0.70 at end of 24 weeks. In ESWT group, mean VAS score improved to 3.91±0.72 at 8 weeks and reduced to 2.3±0.68 at end of 24 weeks. PRTEE improved significantly in both the groups, from 85.33±3.29 to 24.87±2.10 in Prolozone group, and from 85.17±2.83 to 41.89±3.17 in ESWT group.Conclusions: The improvement in pain and disability is better in prolozone group than ESWT (p<0.05) in chronic lateral epicondylitis.

scholarly journals Predictive factors of successful extracorporeal shockwave lithotripsy (ESWL) for renal stones: evidence of retrospective study

2019 ◽  
Vol 2 (1) ◽  
pp. 60-64
Author(s):  
Shukur Mahmood Yaseen ◽  
Saad Ahmed Ali Jadoo ◽  
Ayad Aziz Abdullah ◽  
Anmar Shukur Mahmood ◽  
Wassan Nasrat Abd Al-wahaab
Keyword(s):  
Retrospective Study ◽  
Linear Regression ◽  
Multiple Linear Regression ◽  
Predictive Factors ◽  
Predictive Factor ◽  
Renal Stone ◽  
Renal Stones ◽  
Extracorporeal Shockwave Lithotripsy ◽  
Shockwave Lithotripsy ◽  
Extracorporeal Shockwave

Background: Extracorporeal shockwave lithotripsy (ESWL) has proved to be effective in treating ureterolithiasis. This study aimed to investigate the predictive factors related to success ESWL among patient presented with renal stone. Methods: A retrospective study was conducted among 40 patients who underwent ESWL at the urology department, Baquba Teaching Hospital, Diyala University, Iraq. Data was collected between1st October 2018 and 31st January 2019 for renal stones diagnosed by non-enhanced spiral computed tomography (NCCT). The success rate defined as no stone or the remnant stones < 4 mm. We analyzed predictive factors by using multiple linear regression. Results: The success rates ranged from 50-90%. In the univariate analysis, body mass index (BMI), skin-to-stone distance (SSD)and the renal stone-attenuation value (in Hounsfield units, HU) were found to be significantly correlated with the outcome of ESWL (p<0.05). However, in the multiple linear regression, only the HU (B = -0.619, P < 0.0001; 95% confidence interval [CI]:0.03 to 0.07) was theindependent predictive factor. Conclusion: Hounsfield Unit is an independent predictive factor influencing the success of ESWL for treating renal stones.

Sign in / Sign up

Export Citation Format

Share Document